These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 2527803

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
    Braakman E, Goedegebuure PS, Vreugdenhil RJ, Segal DM, Shaw S, Bolhuis RL.
    Int J Cancer; 1990 Sep 15; 46(3):475-80. PubMed ID: 1975566
    [Abstract] [Full Text] [Related]

  • 3. Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.
    Van Seventer GA, Van Lier RA, Kuijpers KC, Spits H, Melief CJ.
    Eur J Immunol; 1988 Dec 15; 18(12):1973-8. PubMed ID: 2905994
    [Abstract] [Full Text] [Related]

  • 4. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M, Suto R, Obata Y, Udono H, Takahashi T, Shiku H, Nakayama E.
    J Exp Med; 1991 Jul 01; 174(1):193-201. PubMed ID: 1905338
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and functional association between CD8 and H-2 at the surface of a T cell clone.
    Auphan N, Boyer C, Andre P, Bongrand P, Schmitt-Verhulst AM.
    Mol Immunol; 1991 Aug 01; 28(8):827-37. PubMed ID: 1678858
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H, Ikemoto M, Yokoyama A, Kamitani T, Yamashita N, Maruyama M, Yano S.
    Cell Immunol; 1991 Jan 01; 132(1):127-39. PubMed ID: 1829651
    [Abstract] [Full Text] [Related]

  • 7. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M.
    J Exp Med; 1990 Jun 01; 171(6):1965-79. PubMed ID: 1972176
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J, Waks T, Eshhar Z.
    Eur J Immunol; 1991 Oct 01; 21(10):2507-15. PubMed ID: 1915555
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
    Ferrini S, Sforzini S, Cambiaggi A, Poggi A, Meazza R, Canevari S, Colnaghi MI, Moretta L.
    Int J Cancer; 1994 Mar 15; 56(6):846-52. PubMed ID: 7907079
    [Abstract] [Full Text] [Related]

  • 12. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V, Schild HJ, Gückel B, von Hoegen P.
    Immunol Cell Biol; 1993 Aug 15; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
    Quinones RR, Segal DM, Henkart P, Perez P, Gress RE.
    J Immunol; 1989 Apr 01; 142(7):2200-6. PubMed ID: 2466891
    [Abstract] [Full Text] [Related]

  • 14. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L, Potter TA, Kane KP.
    J Exp Med; 1996 Nov 01; 184(5):1671-83. PubMed ID: 8920857
    [Abstract] [Full Text] [Related]

  • 15. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA, Newman W, Shimizu Y, Nutman TB, Tanaka Y, Horgan KJ, Gopal TV, Ennis E, O'Sullivan D, Grey H.
    J Exp Med; 1991 Oct 01; 174(4):901-13. PubMed ID: 1717633
    [Abstract] [Full Text] [Related]

  • 16. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F, Leo O, Van Mechelen M, Urbain J, Slaoui M.
    Immunology; 1989 Sep 01; 68(1):1-6. PubMed ID: 2530152
    [Abstract] [Full Text] [Related]

  • 17. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
    Rivas A, Koide J, Laus R, Engleman EG.
    J Immunol; 1990 Jul 15; 145(2):470-6. PubMed ID: 2142178
    [Abstract] [Full Text] [Related]

  • 18. Human thymocytes expressing gamma/delta T-cell receptors.
    Mingari MC, Varese P, Bottino C, Tambussi G, Moretta L.
    Int J Cancer Suppl; 1989 Jul 15; 4():39-42. PubMed ID: 2530183
    [Abstract] [Full Text] [Related]

  • 19. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.
    Moretta A, Ciccone E, Pantaleo G, Tambussi G, Bottino C, Melioli G, Mingari MC, Moretta L.
    Immunol Rev; 1989 Oct 15; 111():145-75. PubMed ID: 2697680
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.
    Oshimi K, Oshimi Y, Yamada O, Wada M, Hara T, Mizoguchi H.
    J Immunol; 1990 May 01; 144(9):3312-7. PubMed ID: 2139452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.